Table 2.
Association of miR-339-5p expression with clinicopathological data from breast cancer patients
| Variable | n | MiR-339-5p expression, n (%) | P value |
|---|---|---|---|
| Age (years) | |||
| ≤35 | 6 | 0 (0) | 0.12 |
| 35-55 | 48 | 18 (37.5) | |
| > 55 | 36 | 9 (25.0) | |
| Tumor size (cm) | |||
| ≤2 | 4 | 2 (50.0) | 0.67 |
| 2-5 | 68 | 20 (29.4) | |
| > 5 | 18 | 5 (27.8) | |
| Lymph node metastases | |||
| 0 | 29 | 14 (48.3) | 0.018 |
| 1-3 | 33 | 9 (27.3) | |
| > 3 | 28 | 4 (14.3) | |
| Grade | |||
| I | 4 | 1 (25.0) | 0.17 |
| II | 57 | 21 (36.8) | |
| III | 29 | 5 (17.2) | |
| Stage | 0.005 | ||
| I - II | 50 | 21 (42.0) | |
| III - IV | 40 | 6 (15.0) | |
| Estrogen receptor | |||
| - | 57 | 18 (36.1) | 0.67 |
| + | 33 | 9 (27.3) | |
| Progesterone receptor | |||
| - | 56 | 16 (28.6) | 0.70 |
| + | 34 | 11 (32.4) | |
| c-erbB-2 expression | |||
| Low | 59 | 18 (30.5) | 0.89 |
| High | 31 | 9 (29.0) |